Concentric Capital Strategies’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-49,781	Closed	-$7.11M	–	318
2024 Q2	$7.11M	Buy	49,781 +24,010	+93%	+$3.43M	0.36%	45
2024 Q1	$3.31M	Buy	+25,771	New	+$3.31M	0.19%	118